Dimed S.A. Distribuidora de Medicamentos (BVMF:PNVL3)

BVMF:PNVL3 Cash Flow Statement

Financials in millions BRL. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	137.65	124.61	105.51	92.91	86.35	79.43
Depreciation & Amortization	201.58	207.27	210.2	200.15	184.57	157.77
Other Amortization	38.56	23.92	-	-	-	-
Asset Writedown & Restructuring Costs	6.46	4.7	6.56	6.41	2.18	3.47
Stock-Based Compensation	7.38	6.9	6.03	5.61	-	-
Provision & Write-off of Bad Debts	-1.07	-3.02	1.37	0.11	1.11	0.38
Other Operating Activities	132.76	109.15	109.26	63.38	35.51	-1.45
Change in Accounts Receivable	-97.06	-126.46	5.94	-52.95	-76.14	-38.89
Change in Inventory	-116.18	-15.27	-151.19	-103.01	-157.64	-164.46
Change in Accounts Payable	44.07	94.48	-48.94	124.31	89.04	90.45
Change in Income Taxes	51.06	9.24	4.71	15.41	15.76	9.75
Change in Other Net Operating Assets	18.74	37.59	-25	-55.71	24.74	-5.28
Operating Cash Flow	421.01	473.1	224.45	296.62	205.48	131.18
Operating Cash Flow Growth	27.98%	110.78%	-24.33%	44.35%	56.64%	0.15%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-118.39	-122.15	-122.72	-114.42	-149.3	-110.05
Sale (Purchase) of Intangibles	-34.59	-37.94	-35.1	-25.02	-32.34	-25.54
Investment in Securities	-49.12	-223.26	102.13	-57.12	39.07	150.49
Other Investing Activities	-	-	-	-	11.48	-
Investing Cash Flow	-202.1	-383.35	-55.69	-196.56	-131.09	14.91

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Long-Term Debt Issued	-	281.28	281.73	425	150	-
Long-Term Debt Repaid	-	-323.16	-318.39	-453.94	-203.17	-175.3
Net Debt Issued (Repaid)	-111.23	-41.88	-36.66	-28.94	-53.17	-175.3
Issuance of Common Stock	6.48	1.91	1.93	2.08	1.45	0.68
Repurchase of Common Stock	-8.13	-7.78	-4.93	-0.72	-1.61	-20.41
Common Dividends Paid	-29.02	-26.46	-33.17	-28.72	-24.75	-20.44
Other Financing Activities	-64.68	-51.81	-43.89	-41.53	-25.04	-6.29
Financing Cash Flow	-206.58	-126.01	-116.71	-97.83	-103.12	-221.76

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Cash Flow	12.33	-36.25	52.04	2.24	-28.72	-75.67

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	302.62	350.95	101.73	182.2	56.18	21.13
Free Cash Flow Growth	56.63%	245.00%	-44.17%	224.31%	165.85%	-68.50%
Free Cash Flow Margin	5.13%	6.37%	2.06%	4.08%	1.41%	0.66%
Free Cash Flow Per Share	2.01	2.34	0.68	1.22	0.38	0.14
Levered Free Cash Flow	126.68	186.93	-63.9	39.68	-54.03	-69.32
Unlevered Free Cash Flow	220.75	270.64	1.65	103.79	-10.27	-46.12

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Interest Paid	64.68	51.81	43.89	41.53	25.04	6.29
Cash Income Tax Paid	4.91	10.72	10.31	3.56	4.66	4.7
Change in Working Capital	-99.38	-0.41	-214.48	-71.95	-104.24	-108.43

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 24, 2026

Data Sources Report a data error